|
|
|
|
In This Issue:
- UCSF Catalyst News
- Meet the 2015 Catalyst Fellows
- Moving Towards the Clinic, an Update on Past Catalyst Awardees
- Translational Research Funding Opportunities
- Upcoming Events
- Articles from our Partners & Sponsors
|
|
Catalyst News:
- Catalyst Awards
 concluded its Spring 2014 cycle on June 3rd with 12 presentations by program finalists (see list of Awardees), showcasing UCSF’s innovative research and its potential to impact patients’ lives. Sean Bohen, MD, PhD, SVP Research and Early Development at Genentech, opened the day with a talk on how the pharmaceutical companies are using big data to understand disease heterogeneity and to develop therapies that benefit specific patient populations. Phyllis Whiteley, PhD (Mohr Davidow Ventures) and Sam Wu, MD, PhD (MedImmune Ventures), long-time advisors to the Catalyst program, were recognized with an Outstanding Advisor Award for their ongoing commitment and always-thoughtful advice to Catalyst participants. Read full article….
- Digital Health Summer Summit, co-hosted by UCSF’s Center for Digital Health Innovation, brought together researchers, clinicians and private sector to present cutting-edge ideas, to discuss product strategies, and to network. Dr. Aenor Sawyer, head of the Digital Health track of Catalyst Awards and Associate Director of CDHI, led the event. Read more….. and watch videos from the summit.
- Interview June Lee, MD, Director of the Catalyst Program, represented the viewpoint of academic innovators at TTS Global Initiative, Europe - Entente Health Conference in Barcelona, Spain. The panel discussion addressed Opportunities, Challenges, Obstacles & the way(s) Forward in Healthcare Technology Transfer. Watch excerpts.
- Texas Health Catalyst, The value of UCSF’s Catalyst Awards program gets acknowledged by University of Texas at Austin, who recently announced an initiative to build Texas Health Catalyst and model it after UCSF. Our model for enabling translation and fostering academic-industry relationships has now been adopted state-wide, by the UC Center of Accelerated Innovation, and nationally, by UT.
- Catalyst Seminar, Join us for the next Catalyst seminar and panel discussion on the controversial issue of data reproducibility in preclinical research. Panelists include Keith Yamamoto, Vice Chancellor for Research at UCSF; Larry Tabak, Principle Deputy Director, NIH; John Ioannidis, Professor of Health Research Policy at Stanford School of Medicine; Elizabeth Iorns, CEO, Science Exchange; Parker B. Antin, President, FASEB; Sean Muthian, Ph.D., MBA, Director of Strategic Marketing and Collaborations, Sigma-Aldrich. September 17th, light breakfast at 8:30am, panel discussion from 9-10:30am, Byers Auditorium.
- UCCAI winners Announced The University of California Center for Accelerated Innovation has announced the cycle 3 awardees for UCSF. Two of our Spring 2012 Catalyst awardees, have received funding for the Fall 2015 cycle. John Fahy, MD for his project on pathology in asthma exacerbations, and Charles Craik, PhD for his project to develop a probe that can directly sense thrombin proteolytic activity in vivo.
- European Inventor AwardFall 2014, Catalyst awardee, Laura van't Veer wins EIA for Gene-based breast cancer test. Article & Video featuring one of her San Francisco patients.
|
|
Meet the 2015 Catalyst Fellows:
The Catalyst Program would like to introduce its Fall 2015 fellows: Ricardo Lamy, MD, PhD, Assistant Professor in the Dept of Ophthalmology and Cammie Wilson, PhD, postdoctoral scholar at the Cardiovascular Research Institute. Ricardo and Cammie are interested in learning how to speed translation from academic discoveries to health benefits, and will be working closely with the Catalyst team on the Awards program, educational initiatives, and fundraising.
 
Ricardo Lamy, MD, PhD Cammie Wilson, PhD
|
|
Moving Towards the Clinic:
Interoperative Visualization to Optimize Tumor Resections
Mekhail Anwar, MD, PhD, Assistant Professor and Catherine Park, MD, in the department of Radiation Oncology were repeat Catalyst awardees in the Fall of 2012 and Spring 2014 cycles, with a project to develop an imager for real-time intraoperative visualization of tumor margins during resection procedures. In its first Catalyst cycle, the advisors encouraged the team to consider the clinical applications in which such device would have the most impact on patient outcomes and to define target device specifications. Catalyst funding enabled the team to validate new approaches to take a bulky benchtop device to a microfabricated concept and to build collaborations with the Dept of Radiology at UCSF and with Electrical Engineering UC Berkeley, and to secure significant grants from the Department of Defense and Mary Kay Foundation to move the device into the clinical setting. The team is currently characterizing the performance of the device components on models of breast and prostate cancer.
 
Mekhail Anwar, MD, PhD Catherine Park, MD
|
|
Translational Research Funding Opportunities:
- Epilepsy Foundation: New Therapy Commercialization Grant Program. Up to $100K. LOI due Aug 14th;
- Bayer Grants 4 Targets: Novel Drug Targets & Biomarkers in Oncology, Gynecology, Cardiology, Hematology, Ophthalmology. Up to €125K. Due Aug 31st;
- NIH SBIR/STTR Program: Due Sep 5th, Jan 5th, April 5th;
- The Biomarker Factory: funds biomarker projects from early discovery to validation studies. Up to $800K. Rolling deadline;
- Foundation Leducq: Research and technology development in cardiovascular & neurovascular diseases; transatlantic research alliance required. Up to $6M. LOI due Sep 6th;
- Alzheimer's Drug Discovery Foundation: Creating new targets for drug discovery. LOI due Sep 7th;
- Grants4Leads: Funding novel small-molecule leads that relate particularly to the fields of oncology, cardiology, hematology and gynecological therapies. Due Sep 30th;
- Wellcome Trust: Translation fund for innovative projects with an unmet healthcare need. Concept note due Oct 16th;
- Michael J. Fox Foundation: Funding translational and clinical research on Parkinson’s disease. Pre-proposal due Oct 28th;
- NIH/NINDS Office of Translational Research: multiple translational opportunities for technology development in neurological diseases and stroke. Explore opportunities
|
|
Upcoming Events:
UCSF
- Catalyst Seminar: Data Reproducibility in Preclinical Discovery, Is It a Real Issue? Light breakfast at 8:30am, panel discussion from 9-10:30am, Byers Auditorium, Mission Bay, Sept 17th. More info to come….
Community
- ClinPulse Networking Event: What Is The New Patient Experience In Tomorrow’s Clinical Trials? Gennentech, South San Francisco, Register, July 22nd;
- HBA Dinner with June Lee, MD: Translating Discoveries to Products in Academia, Il Fornaio, San Francisco 5:30 pm Register, Event Flyer July 30th;
- CLSA Event: Smooth Sailing For A Successful IPO: CLSA, South San Francisco, CA, Register, Aug 5th;
- SBIR/STRR Webinar: Catalyzing The Next Generation of HealthCare Technologies & New Medicines, Register, Aug 5th;
- Drug Development Forum: Novel Modalities For Oncology: South San Francisco, Register, Aug 6th;
- EUSTM Conference: 3rd Annual Congress of The European Society for Translational Medicine: Vienna, Austria. Register, Sept 1-4th;
- AWIS Summit: 2015 National Summit on Innovation and Entrepreneurship: a Roadmap for Inclusion. Keynote by Janet Napolitano, Oakland, CA. Register, Sept 22nd;
- 17th Annual NIH SBIR/STTR Conference, Learn about the $780 million in NIH funding available for small businesses to perform innovative research & build new business based on their research, Seattle, WA, Register, Oct 27-29th
Sign me up for Catalyst Newsletters & Seminars
|
|
UCSF Catalyst Awards Program
University of California, San Francisco (UCSF)
CTSI, Box 0558
550 16th Street (at corner of 4th St.)
6th Floor, San Francisco, CA 94158
Catalyst Awards Program | UCSF Profiles
|
|
Stay up to date with the Catalyst Team via Twitter, Flickr or email!
|
|
|
|
|
|
|
|
|
